Reply to Besançon et al. regarding ‘Marked improvement in HbA1c following introduction of biosimilar insulin to treatment regimen of children and youth with type 1 diabetes in Mali: A randomised controlled trial’

Documents similaires

• Marked improvement in HbA1c following introduction of biosimilar insulin to treatment regimen of children and youth with type 1 diabetes in Mali: A randomised controlled trial
  par: Stéphane Besançon, et autres
  Publié: (2025)
• Impact of automated insulin delivery on subjective and objective sleep in children and young adults with very high HbA1c : Sleep outcomes from the CO ‐ PILOT randomised controlled trial
  par: Venus R. Michaels, et autres
  Publié: (2025)
• Associations of adipose tissue insulin resistance with fasting blood glucose and HbA1c in adults without diabetes
  par: Ying Wei, et autres
  Publié: (2026)
• Changes in HbA1c and diabetes‐specific quality of life following structured type 1 diabetes education: Exploratory latent profile analysis of outcomes in the DAFNE plus trial
  par: Uffe Søholm, et autres
  Publié: (2026)
• Real‐world use of glucagon‐like peptide‐1 receptor agonists in youth with type 2 diabetes is associated with short‐term improvements in HbA1c
  par: Stephanie L. Samuels, et autres
  Publié: (2024)